Who owns ADMA?
Institutional ownership of ADMA Biologics Inc from Form 13F, Q2 2026
323 institutional managers reported holding ADMA Biologics Inc (ADMA) in Form 13F filings for Q2 2026, with 205,663,510 shares worth $1.7B. The largest reported holder was BlackRock, Inc. Managers that filed both quarters cut a net 6,272,532 shares (-3.0%). 49 opened new positions and 84 sold out.
- Funds holding
- 323
- Value held
- $1.7B
- New / sold out
- 49 / 84
- Net shares, same filers
- -3.0%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of ADMA
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| BlackRock, Inc. | $321M | 18.6% | 38,355,684 | Added |
| State Street Corp | $143M | 8.3% | 17,116,022 | Added |
| Vanguard Capital Management LLC | $84.6M | 4.9% | 10,103,809 | Trimmed |
| Vanguard Portfolio Management LLC | $84.4M | 4.9% | 10,088,490 | Added |
| Rubric Capital Management LP | $78.2M | 4.5% | 9,339,414 | Added |
| Capital Research Global Investors | $73.3M | 4.3% | 8,756,374 | Trimmed |
| First Trust Advisors LP | $65.3M | 3.8% | 7,798,351 | Added |
| Geode Capital Management, LLC | $50.7M | 2.9% | 6,059,984 | Added |
| Caligan Partners LP | $47.9M | 2.8% | 5,725,007 | Added |
| D. E. Shaw & Co., Inc. | $44.1M | 2.6% | 5,274,597 | Added |
| Nantahala Capital Management, LLC | $39.5M | 2.3% | 4,719,986 | New |
| Dimensional Fund Advisors LP | $30.2M | 1.8% | 3,606,208 | Trimmed |
| Goldman Sachs Group Inc | $29.4M | 1.7% | 3,513,583 | Added |
| B Group, Inc. | $27.3M | 1.6% | 3,262,542 | Added |
| Nuveen, LLC | $27.3M | 1.6% | 3,260,349 | Trimmed |
| Duquesne Family Office LLC | $23.3M | 1.4% | 2,784,110 | Added |
| Northern Trust Corp | $20.2M | 1.2% | 2,415,971 | Added |
| Morgan Stanley | $19.0M | 1.1% | 2,265,443 | Trimmed |
| Ranger Investment Management, L.P. | $17.7M | 1.0% | 2,115,417 | Trimmed |
| Charles Schwab Investment Management Inc | $17.5M | 1.0% | 2,092,594 | Trimmed |
| Two Sigma Investments, LP | $16.9M | 1.0% | 2,019,887 | Trimmed |
| Kennedy Capital Management LLC | $14.7M | 0.9% | 1,755,152 | Added |
| Vanguard Fiduciary Trust Co | $13.8M | 0.8% | 1,654,613 | Added |
| Fundsmith LLP | $13.8M | 0.8% | 1,649,493 | Unchanged |
| Bank of America Corp | $13.8M | 0.8% | 1,647,647 | Trimmed |
Share of 13F holdings is each fund's shares as a share of the 205,663,510 ADMA shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Rubric Capital Management LP Added+$63.0M
- First Trust Advisors LP Added+$62.3M
- Nantahala Capital Management, LLC New+$39.5M
- D. E. Shaw & Co., Inc. Added+$39.5M
- State Street Corp Added+$25.4M
- BlackRock, Inc. Added+$12.8M
- Life Cycle Investment Partners Ltd New+$12.7M
- Kennedy Capital Management LLC Added+$11.2M
- Duquesne Family Office LLC Added+$10.4M
- Vanguard Portfolio Management LLC Added+$10.2M
Biggest sellers in Q2 2026
- American Century Companies Inc Trimmed-$38.2M
- Citadel Advisors LLC Trimmed-$37.2M
- Invesco Ltd. Trimmed-$29.9M
- Point72 Asset Management, L.P. Trimmed-$24.1M
- Nuveen, LLC Trimmed-$23.8M
- Capital Research Global Investors Trimmed-$20.4M
- Jane Street Group, LLC Trimmed-$20.0M
- Bank of America Corp Trimmed-$19.7M
- Millennium Management LLC Trimmed-$19.1M
- Franklin Resources Inc Trimmed-$17.9M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $380M and sold $437M; 89 added and 147 trimmed.
Schedule 13D and 13G filings on ADMA
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-10STATE STREET CORP SCHEDULE 13G filed by ADMA Biologics IncSchedule 13G
- 2026-08-07STATE STREET CORP SCHEDULE 13G filed by ADMA Biologics IncSchedule 13G
- 2025-08-11STATE STREET CORP SCHEDULE 13G filed by ADMA Biologics IncSchedule 13G
- 2025-05-13STATE STREET CORP SCHEDULE 13G filed by ADMA Biologics IncSchedule 13G
- 2025-05-09Invesco Ltd. SCHEDULE 13G filed by ADMA Biologics IncSchedule 13G
Questions about ADMA ownership
- Who owns ADMA stock?
- 323 institutional investment managers reported ADMA positions in their Form 13F filings for Q2 2026, holding 205,663,510 shares worth $1.7B in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling ADMA?
- In Q2 2026, 49 managers opened new ADMA positions, 89 added, 147 trimmed and 84 sold out. Managers that filed in both quarters sold a net 6,272,532 shares.
- How current is this ADMA institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to ADMA by CUSIP. Options are left out. ADMA news and filings · ADMA insider trades · Top funds